Skip to Content
Merck
  • Identification of erythroferrone as an erythroid regulator of iron metabolism.

Identification of erythroferrone as an erythroid regulator of iron metabolism.

Nature genetics (2014-06-02)
Léon Kautz, Grace Jung, Erika V Valore, Stefano Rivella, Elizabeta Nemeth, Tomas Ganz
ABSTRACT

Recovery from blood loss requires a greatly enhanced supply of iron to support expanded erythropoiesis. After hemorrhage, suppression of the iron-regulatory hormone hepcidin allows increased iron absorption and mobilization from stores. We identified a new hormone, erythroferrone (ERFE), that mediates hepcidin suppression during stress erythropoiesis. ERFE is produced by erythroblasts in response to erythropoietin. ERFE-deficient mice fail to suppress hepcidin rapidly after hemorrhage and exhibit a delay in recovery from blood loss. ERFE expression is greatly increased in Hbb(th3/+) mice with thalassemia intermedia, where it contributes to the suppression of hepcidin and the systemic iron overload characteristic of this disease.

MATERIALS
Product Number
Brand
Product Description

Erythropoietin, BRP, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Erythropoietin human, EPO, recombinant, expressed in HEK 293 cells, suitable for cell culture